Indian Journal of Hematology and Blood Transfusion

Scope & Guideline

Elevating Knowledge: Your Source for Hematology Excellence

Introduction

Welcome to your portal for understanding Indian Journal of Hematology and Blood Transfusion, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN0971-4502
PublisherSPRINGER INDIA
Support Open AccessNo
CountryIndia
TypeJournal
Convergefrom 2000 to 2003, from 2007 to 2024
AbbreviationINDIAN J HEMATOL BLO / Indian J. Hematol. Blood Transfus.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI 110 001, INDIA

Aims and Scopes

The Indian Journal of Hematology and Blood Transfusion focuses on a broad range of topics within hematology and transfusion medicine, emphasizing clinical research, innovative therapies, and patient outcomes. The journal serves as a platform for disseminating significant findings that advance the understanding and treatment of hematological disorders.
  1. Clinical Hematology Research:
    The journal publishes original research articles that explore various aspects of hematology, including studies on hematological malignancies, anemias, and bleeding disorders, with a focus on clinical implications and treatment outcomes.
  2. Transfusion Medicine:
    Research related to blood transfusion practices, safety, and efficacy is a core area of focus. This includes studies on blood donation, transfusion reactions, and the development of new transfusion protocols.
  3. Innovative Therapeutic Approaches:
    The journal highlights advancements in therapeutic strategies for managing hematological conditions, including novel drug therapies, stem cell transplantation, and gene therapies.
  4. Laboratory Techniques and Diagnostics:
    A significant emphasis is placed on the development and evaluation of laboratory techniques for diagnosing hematological disorders, encompassing molecular diagnostics, flow cytometry, and imaging techniques.
  5. Public Health and Epidemiology in Hematology:
    The journal addresses public health issues related to hematology, including epidemiological studies on blood disorders, awareness campaigns, and the impact of socio-economic factors on hematological health.
  6. Patient-Centered Care:
    Research exploring the quality of life, psychological aspects, and patient experiences in hematological care is a growing area of interest, reflecting a holistic approach to treatment.
The Indian Journal of Hematology and Blood Transfusion has also identified several emerging themes that reflect current trends in hematology research and practice, indicating areas of growing interest and importance.
  1. Personalized Medicine and Genomics:
    There is an increasing focus on personalized medicine, particularly in the context of hematological malignancies, where genomic profiling and targeted therapies are becoming prominent.
  2. COVID-19 Related Hematology:
    Research addressing the impact of COVID-19 on hematological patients, including complications and management strategies, has surged, reflecting the pandemic's significant influence on clinical practice.
  3. Pediatric Hematology:
    An increasing number of studies focus on pediatric hematology, particularly regarding conditions like thalassemia and leukemia, highlighting the need for tailored approaches in younger populations.
  4. Novel Therapeutic Agents and Techniques:
    Emerging therapies, such as CAR-T cell therapy and novel anticoagulants, are being increasingly explored, showcasing innovation in treatment methodologies.
  5. Quality of Life and Patient-Centered Research:
    There is a growing trend towards exploring the quality of life and psychological impacts of hematological disorders and their treatments, emphasizing a holistic view of patient care.

Declining or Waning

Over recent years, certain themes within the Indian Journal of Hematology and Blood Transfusion have seen a decline in frequency or focus. This may reflect shifting priorities in research or changes in clinical practice.
  1. Traditional Hematological Practices:
    As the field progresses with new technologies and therapies, traditional practices in hematology, such as manual blood counts and basic transfusion protocols, are becoming less frequently reported.
  2. Single Case Reports:
    The journal has seen a decrease in the publication of single case reports, suggesting a shift towards more robust, larger cohort studies that provide broader insights into clinical practices.
  3. Basic Science Research:
    Although foundational research remains important, there is a noticeable decline in publications focusing purely on basic science without direct clinical application, as the journal aims for a more translational approach.
  4. Historical Reviews and Observational Studies:
    The frequency of historical reviews and observational studies has decreased, with a preference for studies that employ more rigorous methodologies such as randomized controlled trials or systematic reviews.

Similar Journals

Hematology-American Society of Hematology Education Program

Transforming Hematology through Comprehensive Learning
Publisher: AMER SOC HEMATOLOGYISSN: 1520-4391Frequency: 1 issue/year

Hematology-American Society of Hematology Education Program is a premier peer-reviewed journal dedicated to advancing the field of hematology through comprehensive educational content. Published by the American Society of Hematology, this journal plays a crucial role in disseminating knowledge to researchers, clinicians, and students in hematology and related disciplines. With an impressive Q1 status in the field, it ranks among the top journals at the forefront of hematological research, as evidenced by its 60th percentile ranking in Scopus' Medicine - Hematology category. Although it does not offer open access, the journal provides invaluable insights and educational resources from leading experts, focusing on the latest advancements, treatment protocols, and evolving understanding of blood disorders. Covering a wide range of topics, from basic research to clinical applications, this journal is essential for anyone seeking to deepen their expertise and stay informed on the latest developments in hematology. For further engagement, readers can access insightful articles published since 2001, ensuring a rich repository of knowledge for ongoing research and clinical excellence.

TRANSFUSION MEDICINE REVIEWS

Advancing the frontiers of transfusion medicine.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0887-7963Frequency: 4 issues/year

TRANSFUSION MEDICINE REVIEWS is a prestigious journal dedicated to the advanced study of transfusion medicine and its related fields, published by W B SAUNDERS CO-ELSEVIER INC. With an outstanding reputation, it boasts an impressive impact factor and consistently ranks in the top quartile (Q1) across multiple categories, including Biochemistry (Medical), Clinical Biochemistry, and Hematology. Researchers will find valuable insights through its extensive coverage of pertinent topics, with a focus on the integration of clinical practices and laboratory science. While the journal does not currently offer open access, its content remains accessible through various institutional subscriptions, ensuring that vital information is available to the global scientific community. With a continuous publication history from 1987 to 2024, TRANSFUSION MEDICINE REVIEWS serves as a vital resource for academics, healthcare professionals, and students who seek to stay abreast of the latest research findings and clinical practices in transfusion medicine.

Transfusionsmedizin

Exploring the forefront of transfusion therapy advancements.
Publisher: GEORG THIEME VERLAG KGISSN: 2191-8805Frequency: 4 issues/year

Transfusionsmedizin is a premier journal dedicated to the field of transfusion medicine, published by the renowned GEORG THIEME VERLAG KG. With an ISSN of 2191-8805 and an E-ISSN of 2191-8813, this journal serves as a vital platform for disseminating cutting-edge research and clinical advancements in blood transfusion practices. Although it operates under a subscription model, the journal is committed to high-quality peer-reviewed content that addresses contemporary challenges and innovations in transfusion therapy. By fostering dialogue among researchers, clinicians, and students, Transfusionsmedizin aims to advance patient care and enhance the safety and efficacy of transfusion practices globally. Its contributions are essential for professionals engaged in transfusion science, hematology, and related medical fields, solidifying its reputation as a critical resource for staying abreast of the latest developments in transfusion research.

GEMATOLOGIYA I TRANSFUZIOLOGIYA

Pioneering Research for a Healthier Tomorrow
Publisher: MINISTERSTVO ZDRAVOOKHRANENIYAISSN: 0234-5730Frequency: 4 issues/year

GEMATOLOGIYA I TRANSFUZIOLOGIYA is an esteemed journal published by the MINISTERSTVO ZDRAVOOKHRANENIYA in the Russian Federation, focusing on the vital fields of hematology and transfusion medicine. With a rich history dating back to its inception in 1983, the journal plays a significant role in disseminating critical research and advancements in these areas, particularly relevant given the evolving landscape of medical science. As a recognized publication, it is indexed in Scopus and holds a Q4 category ranking in Hematology for 2023, reflecting its niche but important contributions to the field. Researchers, healthcare professionals, and students can look forward to a variety of peer-reviewed articles that not only address contemporary issues but also pave the way for innovative practices in hematology. Although it does not currently offer open access, the journal remains a valuable resource for those seeking to stay informed about the latest findings and developments.

Hematology

Unlocking Potential: Pioneering Research in Blood Disorders
Publisher: TAYLOR & FRANCIS LTDISSN: 1024-5332Frequency: 1 issue/year

Hematology is a distinguished open-access journal published by Taylor & Francis Ltd, dedicated to advancing research and knowledge in the field of hematology. Established in 1996, the journal has continually evolved to meet the needs of a growing community of researchers and practitioners, providing a vital platform for disseminating innovative findings and clinical insights. With its impact factor reflecting a robust commitment to quality scholarship, Hematology has achieved a respectable position in its category as evidenced by its Q3 ranking in the Hematology category and ranks #85 out of 137 in the Scopus index, which positions it in the 38th percentile among its peers. The journal’s open-access policy, initiated in 2019, further enhances its reach and accessibility, allowing a broad audience of professionals, researchers, and students to engage with high-quality research without barriers. By covering a wide range of topics related to blood disorders, treatment methodologies, and emerging therapies, Hematology stands as an essential resource for those dedicated to innovation in this critical area of healthcare.

Egyptian Journal of Haematology

Fostering Collaboration for a Healthier Tomorrow in Hematology
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1110-1067Frequency: 4 issues/year

The Egyptian Journal of Haematology, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, stands as a pivotal resource in the field of hematology, particularly within the context of Egypt and the broader Middle Eastern region. This journal is dedicated to disseminating high-quality research that explores the latest advancements in blood disorders, hematologic malignancies, and transfusion medicine. With a focus on original research, case studies, and reviews, it aims to provide a comprehensive platform for hematologists, researchers, and healthcare professionals to enhance their understanding and management of hematological conditions. Although it is not an open-access journal, the rigorous peer-review process ensures that only the most impactful studies are published, contributing to the journal's reputation in the academic community. The Egyptian Journal of Haematology serves as an essential tool for advancing knowledge, improving clinical outcomes, and fostering collaboration among experts in the field.

Journal of Blood Medicine

Empowering Research: Your Gateway to Innovations in Hematology
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-2736Frequency: 1 issue/year

The Journal of Blood Medicine, published by DOVE MEDICAL PRESS LTD, stands as a vital resource in the field of hematology, focusing on the latest research developments and clinical advancements in blood medicine. With an impact factor reflective of its growing relevance, this open-access journal has been delivering quality scholarly work since 2010, ensuring that critical research is readily available to the global scientific community. The journal operates under an open-access model, further enhancing its dissemination and accessibility to researchers, professionals, and students alike. In the 2023 rankings, it secured a Q3 category status within hematology and achieved a commendable 76th rank out of 137 in Scopus listings, indicating its commitment to quality and innovation in this specialized area. Located in New Zealand, the journal's diverse topics encompass clinical research, treatment modalities, and emerging therapies, contributing significant insights vital for shaping future advancements in blood medicine.

TRANSFUSION MEDICINE

Advancing transfusion practices for better patient outcomes.
Publisher: WILEYISSN: 0958-7578Frequency: 6 issues/year

TRANSFUSION MEDICINE, ISSN 0958-7578, is a prestigious journal published by Wiley that focuses on advancing the field of transfusion medicine. Since its inception in 1991, the journal has provided a vital platform for the dissemination of innovative research findings, clinical practices, and policy developments impacting blood transfusion and hematology. With an impressive repository of peer-reviewed articles, TRANSFUSION MEDICINE aims to facilitate the exchange of knowledge among hematologists, transfusion practitioners, and related professionals to enhance patient outcomes. Currently positioned in the third quartile (Q3) of Hematology in the 2023 category rankings, the journal ranks #83 out of 137 in the Scopus database, highlighting its relevance and influence in the field, albeit with a 39th percentile ranking. Although it does not offer open access options, the dissemination of critical findings continues to support the advancement of transfusion practices on a global scale. Researchers, professionals, and students alike are encouraged to engage with the valuable insights published within this journal as it converges to 2024 and beyond.

Hematologie

Empowering the Future of Hematological Sciences
Publisher: JOHN LIBBEY EUROTEXT LTDISSN: 1264-7527Frequency: 6 issues/year

Hematologie is a highly regarded journal in the field of hematology, published by JOHN LIBBEY EUROTEXT LTD. With an ISSN of 1264-7527 and an E-ISSN of 1950-6368, this journal has established itself as a vital resource for researchers, clinicians, and students dedicated to advancing the understanding of blood disorders and treatments. Although the journal's coverage in Scopus was discontinued in 2018, it has continually provided invaluable insights and research findings. The journal aims to foster knowledge sharing and discussion in hematology, exploring innovative methodologies and emerging trends in the field. With a commitment to quality research, Hematologie remains an essential platform for disseminating critical findings that can drive clinical practice and influence future studies in hematological sciences.

BLOOD REVIEWS

Advancing the frontiers of Hematology and Oncology.
Publisher: CHURCHILL LIVINGSTONEISSN: 0268-960XFrequency: 6 issues/year

BLOOD REVIEWS is a highly regarded journal published by Churchill Livingstone, specializing in the fields of Hematology and Oncology. With an impressive Q1 ranking in both disciplines and placing in the top 10% of its peer categories according to Scopus metrics, it provides an essential platform for the dissemination of cutting-edge research and reviews pertaining to blood disorders and cancer treatment. Since its inception in 1987 and continuing through 2024, the journal has established itself as a cornerstone for healthcare professionals, researchers, and students who seek to advance their understanding of hematologic and oncologic topics. While not an open-access journal, BLOOD REVIEWS retains a reputation for delivering high-quality, peer-reviewed articles that foster dialogue and innovation within the scientific community. For those in the United States and beyond, the journal serves as a vital resource, housed at the Journal Production Department in Edinburgh, Scotland, ensuring accessibility and a global reach in its critical academic contributions.